REQUEST A DEMO
Total
USD $0.00
Search more companies

Solve Medical Sp z oo (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Solve Medical Sp z oo Profile Updated: July 25, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Solve Medical Sp z oo is an enterprise based in Poland. Its main office is in Bialystok. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on March 05, 2019. The company’s latest financial report indicates a net sales revenue increase of 118.44% in 2022. Its’ total assets recorded a negative growth of 26.92%. In 2022, Solve Medical Sp z oo’s net profit margin decreased by 1.33%.

Headquarters
Ul. Wladyslawa Wysockiego 4/5
Bialystok; Podlaskie; Postal Code: 15-167

Contact Details: Purchase the Solve Medical Sp z oo report to view the information.

Website: http://solvemedical.pl

Basic Information
Outstanding Shares:
Purchase the Solve Medical Sp z oo report to view the information.
Registered Capital:
Purchase the Solve Medical Sp z oo report to view the information.
Incorporation Date:
March 05, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Solve Medical Sp z oo report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
118.44%
Total operating revenue
118.45%
Operating profit (EBIT)
75.34%
Net Profit (Loss) for the Period
78.53%
Total assets
-26.92%
Total equity
86.9%
Operating Profit Margin (ROS)
-1.77%
Net Profit Margin
-1.33%
Return on Equity (ROE)
-2.18%
Debt to Equity Ratio
-0.04%
Quick Ratio
0.93%
Cash Ratio
0.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?